Wells Fargo’s Artiva Biotherapeutics, Inc. Common Stock ARTV Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$3.12K	Sell	2,064 -10,595	-84%	-$16K	﹤0.01%	5690
2025 Q1	$38K	Buy	12,659 +4,043	+47%	+$12.1K	﹤0.01%	5039
2024 Q4	$86.8K	Buy	8,616 +3,361	+64%	+$33.9K	﹤0.01%	4784
2024 Q3	$81.2K	Buy	+5,255	New	+$81.2K	﹤0.01%	4739